Why the study?
Does dobutamine reverse the cardiodepressive effects of metoprolol in patients with acute myocardial infarction?
Does dobutamine reverse the cardiodepressive effects of metoprolol in patients with acute myocardial infarction?
Dobutamine can effectively and safely counteract the undesirable cardiodepressive effects of beta-blockers like metoprolol in the setting of acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
May support dobutamine for metoprolol-induced cardiodepression in AMI; hypothesis-generating case report requiring prospective validation.
1 Ten patients with acute myocardial infarction were infused dobutamine in increasing doses up to 15 microgram kg--1 min--1. 2 Metoprolol (total dose 15 mg) was then given intravenously to nine of these patients and the beta-adrenoceptor against effects produced by dobutamine were effectively reversed. 3 Nine patients with acute myocardial infarction pretreated with metoprolol (15 mg) were infused dobutamine 15 microgram kg--1 min--1 for 10 min. This resulted in effective reversal of the beta-adrenoceptor antagonist effects induced by metoprolol, without the occurrence of serious arrhythmias or other unwanted effects. 4 Dobutamine may be valuable in counteracting any undesirable cardiodepressive effects of beta-adrenergic receptor blocking drugs (especially the cardioselective agents) in patients with acute myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Waagstein et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: